Difference in blood pressure levels in patients with hypertension with and without refillable prescription program in family medicine Authors: Brian González-Pérez, Rebeca Benítez Torres, Francisco C. Martínez, Raúl de León Escobedo, Ricardo Salas Flores, Alma A. Peña Maldonado Published: 2025 ABSTRACT ABSTRACTArterial hypertension (AHT) is a chronic disease characterized by persistently elevated blood pressure levels in the arteries. The reported prevalence of AHT in Mexico is 31.5%. Due to the multiple complications that uncontrolled AHT can cause, it is necessary for healthcare personnel to manage this condition professionally. However, the increasing population size and lack of infrastructure to treat both existing and new patients have needed improvements in treatments and patient education on their responsibility in managing their condition. It is within this framework that the Refillable Prescription Program (RPP) was introduced. Additionally, an earlier study suggested that AHT patients enrolled in the RPP in a different population showed a sustained decrease in blood pressure levels after one year of follow-up, resulting in a lower risk of complications related to this condition. Introduction Quality of care is a priority for the well-being and health of the population. Therefore, the provision of quality services must guarantee compliance with care standards and respond to the expectations and preferences of users. In this sense, sufficient resources are needed for prompt access to services, the implementation of technically adequate processes, and continuous interaction and participation between healthcare personnel and users, the latter with the purpose of decision-making to address their health needs.[12] In this regard, Mexico faces significant public health challenges, where the increase in chronic diseases, particularly hypertension (HTN), has become a critical priority. More than 70% of the adult population suffers from overweight or obesity, 12% from diabetes, and nearly 50% live with hypertension. These patients, who demand constant and high-quality healthcare, face an elevated risk of complications, disability, and premature death.[3] HTN, a chronic disease that significantly increases morbidity and mortality, ranks as the third leading cause of disability-adjusted life years. Its asymptomatic nature in initial stages complicates prompt diagnosis, resulting in a prevalence of 30–45% in adults, exceeding 60% in those over 60 years of age.[456] The absence of warning symptoms in early-stage HTN complicates its detection, but uncontrolled progression can trigger severe conditions: heart failure, myocardial infarction, stroke, vision problems, and kidney disease. These damages result from the structural alterations that elevated blood pressure induces in the arterial system, affecting vital organs such as the brain, heart, and kidneys. The most frequent complications include atherosclerotic cardiovascular disease, coronary artery disease, heart failure, chronic kidney disease, and peripheral artery disease. Given this scenario, HTN demands priority attention in Mexico, where its prevalence reaches 49.4% in adults, with severe consequences due to inadequate management.[3456] The Mexican Social Security Institute (IMSS), in its 2013–2018 work plan, implemented the Refillable Prescription Program (RPP) as part of strategies to consolidate preventive and curative healthcare. This program involves issuing three prescriptions (one for each month) in a single consultation for patients with controlled chronic diseases, including hypertension—a strategy that improves medical consultations. However, there is limited evidence on its efficacy, particularly in blood pressure control. Therefore, this study was conducted to determine whether there is a significant difference in blood pressure levels between hypertensive patients with and without the RPP at IMSS Family Medicine Unit No. 77 in Cd. Madero.[789] Materials and Methods An analytical cross-sectional study was conducted, approved by the Local Committee for Health Research 2804 of the Mexican Social Security Institute (IMSS), at Family Medicine Unit No. 77 (UMF77) in Cd. Madero, Tamaulipas. Simple random sampling was used, and the sample size was calculated using the difference of proportions formula, resulting in a sample of 364 participants. Inclusion criteria Patients of both sexes aged 18–65, beneficiaries of UMF77-IMSS with a confirmed diagnosis of hypertension, on pharmacological treatment for at least 3 months, who agreed to take part by signing informed consent, and who were literate. Exclusion criteria Patients with resistant hypertension, psychiatric diagnoses, those who missed any scheduled medical appointment in the 3 months before the study, and pregnant women were excluded. Sociodemographic data were collected, including sex, age, occupation, education level, comorbidities, and participation (or not) in the institutional RPP. The inclusion criteria[7] for the program were: Systolic blood pressure <130 mmHg.Diastolic blood pressure <80 mmHg.Controlled for the last 6 months.No other comorbidities.No evidence of acute complications from hypertension. Systolic blood pressure <130 mmHg. Systolic blood pressure <130 mmHg. Diastolic blood pressure <80 mmHg. Diastolic blood pressure <80 mmHg. Controlled for the last 6 months. Controlled for the last 6 months. No other comorbidities. No other comorbidities. No evidence of acute complications from hypertension. No evidence of acute complications from hypertension. The same trained family physician took all measurements. Participants were asked to remove their shoes and wear light clothing. Weight was measured with a precision of ± 0.1 kg using a “BAME” scale (model BAM-420, capacity 140 kg), compliant with Mexican Official Standard NOM-010-SCFI-1994 for non-automated weighing instruments. Height was measured using a portable stadiometer (Seca, Hamburg, Germany; 225 cm, precision ± 0.1 cm). BMI was calculated as weight (kg) divided by height squared (m²), following the IMSS-046-18 Clinical Practice Guidelines for the prevention, diagnosis, and treatment of overweight and exogenous obesity.[1011] Blood pressure was measured with an appropriately sized cuff (covering at least 80% of the arm), with the patient seated, feet together, and the right arm supported at heart level. After the patient rested quietly (no talking or activity) for at least 10 minutes, a pre-calibrated aneroid sphygmomanometer was used. Blood pressure classifications.[12] Optimal: <120/80 mmHg.Normal: 120–129/80–84 mmHg.High: 130–139/85–89 mmHg.Grade I hypertension: 140–159/90–99 mmHg.Grade II: 160–179/100–109 mmHg.Grade III: ≥180/110 mmHg. Optimal: <120/80 mmHg. Optimal: <120/80 mmHg. Normal: 120–129/80–84 mmHg. Normal: 120–129/80–84 mmHg. High: 130–139/85–89 mmHg. High: 130–139/85–89 mmHg. Grade I hypertension: 140–159/90–99 mmHg. Grade I hypertension: 140–159/90–99 mmHg. Grade II: 160–179/100–109 mmHg. Grade II: 160–179/100–109 mmHg. Grade III: ≥180/110 mmHg. Grade III: ≥180/110 mmHg. BMI classifications[13]: Overweight: 25–29.9 kg/m².Obesity grade I: 30–34.9 kg/m².Obesity grade II: 35–39.9 kg/m².Obesity grade III: ≥40 kg/m². Overweight: 25–29.9 kg/m². Overweight: 25–29.9 kg/m². Obesity grade I: 30–34.9 kg/m². Obesity grade I: 30–34.9 kg/m². Obesity grade II: 35–39.9 kg/m². Obesity grade II: 35–39.9 kg/m². Obesity grade III: ≥40 kg/m². Obesity grade III: ≥40 kg/m². Statistical analysis Central tendency and dispersion measures describe quantitative variables; frequencies and percentages describe qualitative variables. Differences between groups were analyzed using Student’s t-test (independent samples) and χ² tests. A two-tailed P < 0.05 was considered statistically significant. Statistical analyses were performed using IBM SPSS Statistics, version 26 (IBM Corp., Armonk, NY, USA; released in 2019). Results This research study included 364 patients with hypertension. The majority were female (53%), the mean age was 60.13 years, the majority had completed high school (35.2%), and were retired (36.3%). Of the total patients, 55.2% (n = 201) were enrolled in the prescription refill program, while 44.8% (n = 163) were not enrolled. The somatometric characteristics of the patients according to their group are shown in Table 1. Table 1General characteristics of the sampleAbsolute population (n=364)Refillable prescription (n=201)Indiviual prescription (n=163)Age*60.13 (+/-10.4)61 (35-86)58.32 (+/- 10.3)58 (35-76)62.35 (+/-10.16)64 (38-86)Weight*74.22 (+/-8.99)75 (52-102)73.201 (+/-9.1)74 (52-102)75.49 (+/-8.72)76 (54-94)Height*1.61 (+/-0.06)1.61 (1.45-1.87)1.60 (+/- 0.06)1.6 (1.45-1.87)1.62 (+/-0.06)162 (1.45-1.78)Body mass indexNormal4412.09%2311.40%2112.9%Overweight20456.04%11858.70%8652.8%Obesity11631.87%6029.90%5634.4%SexFemale19353.00%10451.70%8954.6%Male17147.00%9748.30%7445.4%EscolarityElementary11932.70%6431.80%5533.7%Secondary11732.10%6230.80%5533.7%High school12835.20%7537.30%5332.5%OcupationHousewife7320.10%6130.35%1274.0%Employee9626.40%4421.89%5231.9%Retired13236.30%5125.37%8149.7%Unemployed6317.30%4522.39%1811.0%Data expressed in frequency and percentage. *Mean (SD), Median (Range) General characteristics of the sample Data expressed in frequency and percentage. *Mean (SD), Median (Range) Likewise, regarding the incidence of other concomitant conditions, we found a strong association between hypertension and other chronic metabolic disorders, such as obesity, overweight, cardiovascular disease and diabetic nephropathy, as at least 361 patients (99.2%) suffered from another condition simultaneously at the time of the study [see Table 2]. Table 2Incidence of comorbidities and time of progressionAbsolute population (n=364)Refillable prescription (n=201)Individual prescription (n=163)With comorbidities36199.20%20099.50%16198.80%Without comorbidities30.80%10.50%21.20%Time of progression6.42 (+/- 3.345)7 (1-17)6.27 (+/-2.92)7 (1-16)6.6 (+/-3.808)7 (1-17)Data expressed in frequency and percentage. *Mean (SD), Median (Range) Incidence of comorbidities and time of progression Data expressed in frequency and percentage. *Mean (SD), Median (Range) On the overall patient progression, the mean age was 6.42 years (±3.34), with a median of 7 years (range 1-17). By group, patients with a refillable prescription had a mean age of 6.27 years (±2.9), with a median of 7 years (range 1-16), while those without a refillable prescription had a mean age of 6.6 years (±3.8), with a median of 7 years (range 1-17) [see Table 2]. The mean systolic and diastolic blood pressure values of patients within (125.14 [±9.46] and 79.17 [±5.156], systolic and diastolic BP, respectively) and outside (125.54 [±12.34] and 79.51 [±6.2], systolic and diastolic BP, respectively) the prescription refill program were compared. To do this, a Student’s t-test for independent samples was performed with a 95% confidence interval. The results (T for the mean systolic BP = 0.341 and T for the difference in the means of diastolic BP = 0.555) showed no statistically significant difference between the blood pressure values of patients within and outside the prescription refill program [see Table 3]. Table 3Comparison of Blood Pressure Control Metrics Inside and Outside the Repeat Prescription ProgramRefillable prescription (n=201)Individual prescription (n=163)Student's tPearson’s Chi square‡ t ST. E. diff†Sistolic BP mmHg*125.14 (+/- 9.46)125 (110-165)125.54 (+/- 12.34)124 (109-164)-0.3411.175Diastolic BP mmHg*79.17 (+/- 5.156)79 (71-98)79.51 (+/-6.2)79 (71-98)-0.5550.612Hypertensive controlYES12964.2%10463.8%0.941NO7235.8%5936.2%Data expressed as frequencies and percentages. *Mean (SD), Median (Range). †Standard Error Difference with a 95% Confidence Interval. ‡Pearson’s Chi Square with a 95% Confidence Interval Comparison of Blood Pressure Control Metrics Inside and Outside the Repeat Prescription Program Data expressed as frequencies and percentages. *Mean (SD), Median (Range). †Standard Error Difference with a 95% Confidence Interval. ‡Pearson’s Chi Square with a 95% Confidence Interval Likewise, an attempt was made to verify an association between good blood pressure control and patient enrollment in the prescription refill program. Pearson’s Chi-square test was used, with a 95% confidence interval. The result (P = 0.941) showed no association between being part of the prescription refill program and keeping blood pressure levels within control ranges [see Table 3]. Discussion Throughout this study, it has been made clear that high blood pressure in Mexico, in the most recent studies, has a prevalence of 49.4%, being more common in men (44.0% of women versus 55.3%). Thus, to maintain each patient’s blood pressure within control ranges, given the scarcity of resources, health systems face the challenge of optimizing supplies for the care of chronic degenerative diseases.[14151617] Consequently, various strategies based on education, family participation, and recently the refillable prescription strategic project have been implemented, the purpose of which is to optimize scarce existing resources.[1617181920] Therefore, at the Mexican Social Security Institute (IMSS), the refillable prescription project began in 2013 with 1,230 Family Medicine Units. It was later implemented at the Social Security Institute for State Workers (ISSSTE). The project addresses ten chronic degenerative diseases, including diabetes mellitus. While the goal is to reduce the number of medical visits, the impact is centered on financial savings for both the patient and the institution. In addition, the clinical impact is also a reality.[19212223] In a 2015 study conducted by Dr. Romo Guzmán in the state of Aguascalientes, the effectiveness of refillable prescriptions versus traditional prescriptions was evaluated using blood pressure levels in patients diagnosed with hypertension at the primary care level. An average age for refillable prescriptions of 58.4 ± 12.6 years was found. About the sex distribution in their work, 41% of men and 59% of women were studied. In this work, a higher incidence of hypertension diagnosis was observed in females (53%) and men (47%). The average age was 60.13 ± 10.4 years. Most had completed high school (35.2%) and were retired (36.3%) Likewise, we were able to observe that a very good fraction of the population has problems controlling their weight, observing a greater predominance in patients whose BMI was in the “Overweight” and “Obesity” stages, which could lead to greater difficulty in achieving comprehensive and successful therapeutic guidelines, in addition to an increased risk of presenting complications related to poor antihypertensive control in the short and medium term.[24] The association between high blood pressure and diseases such as type 2 diabetes mellitus or obesity has been well studied, with overlapping pathogenetic mechanisms, such that the presence of two or more diseases is common. Among the most common comorbidities in patients with hypertension, diabetes and obesity were found to be 46.4% and 31.8%, respectively. This was closely similar to the 47.6% of patients with diabetes and 32.3% with obesity reported by Mannan et al. in their study.[2526] Despite this, in the current study we were able to verify that there is no evidence of a significant difference in BP levels between patients registered in the RPP versus those who are not. This opens the door to the possibility of initiating patients with adequate control in the program with the monthly consultation regimen, thus gradually freeing up the family medicine consultation schedule in primary care units. Conclusion From the close, day-to-day perspective of family medicine, proper control of hypertension is not just a clinical goal but an opportunity to improve the quality of life for our patients and their families. This silent disease, as common as it is dangerous, challenges us to be consistent, empathetic, and strategic in the care we provide. Every controlled blood pressure reading is a step toward preventing serious complications affecting the heart, kidneys, vision, and life itself. The RPP appears as a useful tool to help follow up for patients with controlled chronic conditions. The findings of this study, which show no statistically significant differences in blood pressure levels between patients enrolled in the program and those who are not, suggest that a larger number of stable patients can be incorporated into this care model without compromising their clinical control. This finding supports the feasibility of optimizing available resources, freeing up space in medical schedules, and directing healthcare efforts toward cases that truly require closer supervision—while also fostering patient autonomy, responsibility, and commitment to their treatment. Implementing and strengthening such strategies can be effective in an overburdened healthcare system, alleviating workload without neglecting the human connection that defines family medicine. Betting on continuity of care and a patient-centered model is the path to achieving more effective and compassionate management of conditions like hypertension. Author contributions All authors have read and approved the final version of this manuscript. Each author contributed significantly to the conception, design, execution, or analysis of the study and agrees that the manuscript represents honest work. Ethical approval The study was approved by the Local Committee for Health Research 2804 of the Mexican Social Security Institute (IMSS), and all procedures followed the ethical standards set by the 1964 Declaration of Helsinki and its subsequent amendments. Conflicts of interest There are no conflicts of interest.